| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle, Smooth | 51 | 2024 | 933 | 3.860 |
Why?
|
| Esophagus | 62 | 2022 | 1017 | 3.790 |
Why?
|
| Synaptic Transmission | 14 | 2016 | 1179 | 3.010 |
Why?
|
| Enteric Nervous System | 9 | 2019 | 189 | 2.680 |
Why?
|
| Gastric Emptying | 6 | 2021 | 233 | 2.260 |
Why?
|
| Barrett Esophagus | 19 | 2011 | 494 | 2.080 |
Why?
|
| Nitric Oxide Synthase Type I | 11 | 2014 | 170 | 1.940 |
Why?
|
| Interstitial Cells of Cajal | 4 | 2016 | 25 | 1.930 |
Why?
|
| Esophagogastric Junction | 39 | 2002 | 312 | 1.910 |
Why?
|
| Esophageal Achalasia | 5 | 2024 | 91 | 1.540 |
Why?
|
| Nitric Oxide | 15 | 2016 | 2128 | 1.520 |
Why?
|
| Opossums | 50 | 2002 | 106 | 1.410 |
Why?
|
| Gastric Fundus | 5 | 2021 | 39 | 1.330 |
Why?
|
| Vagus Nerve | 26 | 2008 | 437 | 1.200 |
Why?
|
| Neuromuscular Junction | 7 | 2016 | 397 | 1.140 |
Why?
|
| Nitrergic Neurons | 3 | 2012 | 5 | 1.130 |
Why?
|
| Gastroparesis | 3 | 2021 | 131 | 1.100 |
Why?
|
| Myosin Type V | 3 | 2014 | 34 | 0.930 |
Why?
|
| Muscle Contraction | 28 | 2011 | 1241 | 0.920 |
Why?
|
| Esophageal Motility Disorders | 1 | 2024 | 44 | 0.910 |
Why?
|
| Diabetes Complications | 2 | 2021 | 1359 | 0.880 |
Why?
|
| Myosin Heavy Chains | 4 | 2014 | 414 | 0.850 |
Why?
|
| Peristalsis | 15 | 2008 | 61 | 0.850 |
Why?
|
| Ileum | 7 | 2012 | 565 | 0.830 |
Why?
|
| Deglutition | 13 | 2001 | 197 | 0.790 |
Why?
|
| Gastrointestinal Motility | 7 | 2019 | 225 | 0.770 |
Why?
|
| Membrane Potentials | 14 | 2012 | 1135 | 0.760 |
Why?
|
| Gastrointestinal Tract | 3 | 2011 | 814 | 0.690 |
Why?
|
| Esophageal Neoplasms | 13 | 2011 | 1581 | 0.690 |
Why?
|
| Stomach Diseases | 1 | 2019 | 134 | 0.630 |
Why?
|
| DNA, Neoplasm | 3 | 2009 | 1758 | 0.600 |
Why?
|
| Manometry | 11 | 2024 | 444 | 0.590 |
Why?
|
| Digestive System | 4 | 2003 | 251 | 0.590 |
Why?
|
| Guanylate Cyclase | 3 | 2016 | 201 | 0.580 |
Why?
|
| Adenocarcinoma | 14 | 2011 | 6347 | 0.550 |
Why?
|
| Potassium Channels | 6 | 2003 | 562 | 0.510 |
Why?
|
| Colon | 4 | 2011 | 1773 | 0.500 |
Why?
|
| Telomerase | 4 | 2008 | 729 | 0.490 |
Why?
|
| Nitroprusside | 5 | 1998 | 275 | 0.460 |
Why?
|
| Presynaptic Terminals | 3 | 2013 | 302 | 0.460 |
Why?
|
| Receptors, Purinergic P2Y1 | 1 | 2013 | 40 | 0.450 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2012 | 173 | 0.450 |
Why?
|
| Chloride Channels | 3 | 2012 | 225 | 0.440 |
Why?
|
| Precancerous Conditions | 4 | 2009 | 971 | 0.440 |
Why?
|
| Animals | 98 | 2021 | 168561 | 0.420 |
Why?
|
| Electric Stimulation | 26 | 2008 | 1770 | 0.410 |
Why?
|
| Reflex | 3 | 2003 | 365 | 0.400 |
Why?
|
| Receptors, Purinergic | 1 | 2011 | 66 | 0.400 |
Why?
|
| Diabetes Mellitus | 3 | 2021 | 5724 | 0.400 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2016 | 686 | 0.400 |
Why?
|
| Neurotransmitter Agents | 6 | 2000 | 647 | 0.390 |
Why?
|
| Potassium Channels, Voltage-Gated | 2 | 2003 | 141 | 0.390 |
Why?
|
| Nitric Oxide Synthase | 6 | 2001 | 916 | 0.380 |
Why?
|
| Respiratory Aspiration | 1 | 2012 | 81 | 0.380 |
Why?
|
| Cell Membrane | 4 | 2009 | 3744 | 0.370 |
Why?
|
| Muscle Relaxation | 7 | 2014 | 142 | 0.370 |
Why?
|
| Gastroenterology | 2 | 2013 | 534 | 0.370 |
Why?
|
| Neurons | 10 | 2019 | 9325 | 0.370 |
Why?
|
| Substance P | 4 | 2000 | 335 | 0.370 |
Why?
|
| Trachea | 2 | 2012 | 1075 | 0.370 |
Why?
|
| Ploidies | 2 | 2008 | 281 | 0.360 |
Why?
|
| Calcium | 9 | 2013 | 5753 | 0.350 |
Why?
|
| Intestines | 4 | 2016 | 1923 | 0.350 |
Why?
|
| Calmodulin | 3 | 2008 | 209 | 0.350 |
Why?
|
| Epithelium | 8 | 2009 | 1680 | 0.340 |
Why?
|
| Intestinal Mucosa | 5 | 2009 | 3038 | 0.340 |
Why?
|
| Duodenogastric Reflux | 1 | 2008 | 5 | 0.330 |
Why?
|
| Pharynx | 6 | 2000 | 413 | 0.330 |
Why?
|
| Telomere | 4 | 2008 | 909 | 0.330 |
Why?
|
| NG-Nitroarginine Methyl Ester | 7 | 2014 | 255 | 0.330 |
Why?
|
| Nerve Endings | 2 | 2007 | 109 | 0.320 |
Why?
|
| Cytosol | 2 | 2009 | 901 | 0.320 |
Why?
|
| Pylorus | 1 | 2008 | 85 | 0.320 |
Why?
|
| Dyneins | 1 | 2008 | 123 | 0.310 |
Why?
|
| Myenteric Plexus | 3 | 2021 | 39 | 0.310 |
Why?
|
| Myosin Light Chains | 3 | 2011 | 121 | 0.310 |
Why?
|
| Bronchi | 1 | 2012 | 840 | 0.310 |
Why?
|
| Vasoactive Intestinal Peptide | 5 | 1996 | 179 | 0.300 |
Why?
|
| NAD | 1 | 2011 | 594 | 0.300 |
Why?
|
| Foreign Bodies | 1 | 2012 | 398 | 0.300 |
Why?
|
| Carbachol | 5 | 1997 | 226 | 0.300 |
Why?
|
| Chloramines | 2 | 2003 | 14 | 0.300 |
Why?
|
| Calcium-Binding Proteins | 3 | 2002 | 1081 | 0.290 |
Why?
|
| Potassium Channel Blockers | 3 | 2003 | 171 | 0.290 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2021 | 3336 | 0.290 |
Why?
|
| Esophageal Diseases | 5 | 1996 | 165 | 0.280 |
Why?
|
| Chlorides | 3 | 1996 | 667 | 0.280 |
Why?
|
| Goblet Cells | 2 | 2009 | 287 | 0.280 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2010 | 581 | 0.280 |
Why?
|
| Bronchoscopy | 1 | 2012 | 860 | 0.270 |
Why?
|
| Metaplasia | 9 | 2009 | 313 | 0.270 |
Why?
|
| Stomach | 6 | 2021 | 697 | 0.270 |
Why?
|
| Periodicals as Topic | 2 | 2013 | 1431 | 0.260 |
Why?
|
| Laryngeal Nerves | 3 | 2001 | 56 | 0.240 |
Why?
|
| Galanin | 3 | 2000 | 44 | 0.230 |
Why?
|
| Neuropeptides | 4 | 1991 | 942 | 0.230 |
Why?
|
| Synapses | 1 | 2013 | 1724 | 0.230 |
Why?
|
| Digestive System Physiological Phenomena | 1 | 2003 | 16 | 0.230 |
Why?
|
| Afferent Pathways | 3 | 2001 | 302 | 0.230 |
Why?
|
| Nerve Fibers | 6 | 1994 | 688 | 0.220 |
Why?
|
| Guinea Pigs | 6 | 2012 | 1386 | 0.220 |
Why?
|
| Mice, Inbred DBA | 3 | 2014 | 642 | 0.210 |
Why?
|
| Mice | 22 | 2021 | 81045 | 0.210 |
Why?
|
| Reflex, Abdominal | 1 | 2001 | 1 | 0.210 |
Why?
|
| Hypertrophy | 1 | 2024 | 568 | 0.210 |
Why?
|
| Gastric Mucosa | 6 | 2007 | 598 | 0.200 |
Why?
|
| Calcitonin Gene-Related Peptide | 4 | 1994 | 305 | 0.200 |
Why?
|
| Receptors, Neurotransmitter | 2 | 2013 | 178 | 0.200 |
Why?
|
| Hyperglycemia | 2 | 2021 | 1368 | 0.200 |
Why?
|
| Bradykinin | 2 | 1992 | 214 | 0.190 |
Why?
|
| Dyspepsia | 1 | 2021 | 114 | 0.180 |
Why?
|
| Mechanoreceptors | 2 | 1992 | 186 | 0.180 |
Why?
|
| Motor Neurons | 3 | 2003 | 851 | 0.180 |
Why?
|
| Cyclic GMP | 3 | 1998 | 408 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 10 | 2014 | 21821 | 0.170 |
Why?
|
| Motilin | 1 | 2019 | 3 | 0.170 |
Why?
|
| Sympathetic Nervous System | 3 | 1992 | 514 | 0.170 |
Why?
|
| Medulla Oblongata | 1 | 2000 | 243 | 0.170 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 2009 | 1801 | 0.170 |
Why?
|
| Receptors, Muscarinic | 3 | 1995 | 156 | 0.170 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2009 | 2906 | 0.170 |
Why?
|
| Enzyme Inhibitors | 6 | 2008 | 3800 | 0.160 |
Why?
|
| Electrophysiology | 8 | 2000 | 1309 | 0.160 |
Why?
|
| Atropine | 11 | 2000 | 244 | 0.160 |
Why?
|
| Potassium | 2 | 1999 | 1336 | 0.160 |
Why?
|
| Postprandial Period | 1 | 2019 | 292 | 0.150 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2010 | 4553 | 0.150 |
Why?
|
| Gastrins | 5 | 1986 | 81 | 0.150 |
Why?
|
| Tyrphostins | 1 | 1997 | 67 | 0.150 |
Why?
|
| Neurons, Afferent | 2 | 1990 | 508 | 0.150 |
Why?
|
| Apoptosis | 5 | 2008 | 9715 | 0.150 |
Why?
|
| Humans | 82 | 2024 | 742088 | 0.150 |
Why?
|
| Niflumic Acid | 2 | 2012 | 10 | 0.150 |
Why?
|
| Male | 80 | 2014 | 349538 | 0.150 |
Why?
|
| Blotting, Western | 4 | 2009 | 5180 | 0.150 |
Why?
|
| Contractile Proteins | 1 | 1998 | 246 | 0.150 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 11695 | 0.150 |
Why?
|
| Subcellular Fractions | 2 | 2008 | 547 | 0.150 |
Why?
|
| Isometric Contraction | 1 | 1997 | 147 | 0.150 |
Why?
|
| Cation Transport Proteins | 1 | 1999 | 327 | 0.150 |
Why?
|
| Amino Acid Oxidoreductases | 2 | 1994 | 151 | 0.150 |
Why?
|
| Pressure | 17 | 1988 | 1203 | 0.150 |
Why?
|
| Ghrelin | 1 | 2019 | 266 | 0.150 |
Why?
|
| Patch-Clamp Techniques | 5 | 2003 | 963 | 0.150 |
Why?
|
| Myosins | 1 | 1998 | 409 | 0.140 |
Why?
|
| Phosphotyrosine | 1 | 1997 | 457 | 0.140 |
Why?
|
| Mast Cells | 1 | 2024 | 1544 | 0.140 |
Why?
|
| Cations | 1 | 1996 | 231 | 0.140 |
Why?
|
| Deglutition Disorders | 3 | 1996 | 604 | 0.140 |
Why?
|
| Mucous Membrane | 7 | 2004 | 670 | 0.140 |
Why?
|
| Immunoprecipitation | 2 | 2009 | 905 | 0.140 |
Why?
|
| Polymyositis | 1 | 1996 | 74 | 0.140 |
Why?
|
| Gastroesophageal Reflux | 8 | 2001 | 782 | 0.130 |
Why?
|
| Pharyngeal Diseases | 2 | 1993 | 132 | 0.130 |
Why?
|
| Chest Pain | 2 | 1996 | 1113 | 0.130 |
Why?
|
| Brain Stem | 1 | 2001 | 844 | 0.130 |
Why?
|
| Heartburn | 1 | 1995 | 68 | 0.130 |
Why?
|
| Neural Inhibition | 4 | 1999 | 598 | 0.130 |
Why?
|
| Myositis, Inclusion Body | 1 | 1996 | 147 | 0.120 |
Why?
|
| Tetrodotoxin | 9 | 1988 | 258 | 0.120 |
Why?
|
| Prostaglandins | 4 | 1980 | 405 | 0.120 |
Why?
|
| Hypoglycemia | 1 | 2021 | 859 | 0.120 |
Why?
|
| Duodenum | 3 | 2008 | 483 | 0.120 |
Why?
|
| Phosphorylation | 5 | 2008 | 8436 | 0.120 |
Why?
|
| Isoenzymes | 3 | 2008 | 1725 | 0.110 |
Why?
|
| Membrane Proteins | 2 | 2009 | 7873 | 0.110 |
Why?
|
| Synaptic Potentials | 1 | 2013 | 43 | 0.110 |
Why?
|
| Esophagitis, Peptic | 4 | 1991 | 77 | 0.110 |
Why?
|
| Apamin | 3 | 1998 | 23 | 0.110 |
Why?
|
| Tyrosine | 1 | 1997 | 1460 | 0.110 |
Why?
|
| Pharyngeal Muscles | 1 | 1993 | 77 | 0.110 |
Why?
|
| Penis | 1 | 2014 | 216 | 0.110 |
Why?
|
| Cromakalim | 1 | 2012 | 19 | 0.110 |
Why?
|
| Adenosine Triphosphate | 3 | 1996 | 2024 | 0.110 |
Why?
|
| Signal Transduction | 1 | 2016 | 23387 | 0.110 |
Why?
|
| Biopsy | 9 | 2009 | 6756 | 0.110 |
Why?
|
| Caffeine | 1 | 1996 | 699 | 0.100 |
Why?
|
| Asphyxia | 1 | 2012 | 57 | 0.100 |
Why?
|
| Eicosanoids | 1 | 1993 | 278 | 0.100 |
Why?
|
| Gap Junctions | 1 | 2013 | 233 | 0.100 |
Why?
|
| History, 20th Century | 3 | 2013 | 2739 | 0.100 |
Why?
|
| Benzylamines | 1 | 2012 | 226 | 0.100 |
Why?
|
| Esophageal Sphincter, Lower | 1 | 2010 | 20 | 0.100 |
Why?
|
| Esophagoscopy | 3 | 2005 | 390 | 0.090 |
Why?
|
| Alu Elements | 1 | 2011 | 119 | 0.090 |
Why?
|
| Rad51 Recombinase | 1 | 2011 | 188 | 0.090 |
Why?
|
| Image Cytometry | 2 | 2008 | 54 | 0.090 |
Why?
|
| History, 21st Century | 2 | 2013 | 1533 | 0.090 |
Why?
|
| Langerhans Cells | 1 | 1991 | 173 | 0.090 |
Why?
|
| Microfilament Proteins | 3 | 2002 | 1152 | 0.090 |
Why?
|
| Mice, Mutant Strains | 2 | 2008 | 1866 | 0.090 |
Why?
|
| Mice, Knockout | 4 | 2011 | 14554 | 0.090 |
Why?
|
| Anesthesia, Local | 1 | 2012 | 268 | 0.090 |
Why?
|
| Ion Channel Gating | 2 | 2003 | 437 | 0.090 |
Why?
|
| Palmitates | 1 | 2009 | 74 | 0.090 |
Why?
|
| Acclimatization | 1 | 1989 | 103 | 0.090 |
Why?
|
| Structure-Activity Relationship | 2 | 2013 | 3133 | 0.090 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2010 | 241 | 0.080 |
Why?
|
| Lipoylation | 1 | 2009 | 64 | 0.080 |
Why?
|
| Female | 60 | 2012 | 379592 | 0.080 |
Why?
|
| Calmodulin-Binding Proteins | 2 | 2002 | 249 | 0.080 |
Why?
|
| Cytokines | 1 | 2024 | 7317 | 0.080 |
Why?
|
| Electric Conductivity | 3 | 2003 | 411 | 0.080 |
Why?
|
| Nitroarginine | 3 | 1993 | 66 | 0.080 |
Why?
|
| Peptides | 3 | 1988 | 4392 | 0.080 |
Why?
|
| Gastric Juice | 10 | 1976 | 64 | 0.080 |
Why?
|
| Nitric Oxide Donors | 3 | 2014 | 121 | 0.080 |
Why?
|
| DNA | 3 | 2008 | 7289 | 0.080 |
Why?
|
| Bezoars | 1 | 2008 | 30 | 0.080 |
Why?
|
| Microdissection | 1 | 2008 | 152 | 0.080 |
Why?
|
| Delayed Diagnosis | 1 | 2012 | 438 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2001 | 575 | 0.080 |
Why?
|
| Duodenal Ulcer | 5 | 1968 | 125 | 0.080 |
Why?
|
| Esophagitis | 3 | 2001 | 152 | 0.080 |
Why?
|
| Immunohistochemistry | 5 | 2011 | 11363 | 0.080 |
Why?
|
| Bile | 1 | 2008 | 296 | 0.070 |
Why?
|
| Antibodies, Blocking | 1 | 2007 | 254 | 0.070 |
Why?
|
| Conscious Sedation | 1 | 2012 | 528 | 0.070 |
Why?
|
| Neoplasm Transplantation | 2 | 2008 | 2085 | 0.070 |
Why?
|
| Anal Canal | 1 | 1990 | 376 | 0.070 |
Why?
|
| Autonomic Fibers, Preganglionic | 2 | 1984 | 7 | 0.070 |
Why?
|
| Nociceptors | 1 | 1990 | 432 | 0.070 |
Why?
|
| Action Potentials | 5 | 1995 | 1814 | 0.070 |
Why?
|
| Calcitonin | 1 | 1988 | 336 | 0.070 |
Why?
|
| Protein Binding | 2 | 2009 | 9387 | 0.070 |
Why?
|
| Catechin | 1 | 2006 | 64 | 0.070 |
Why?
|
| Molecular Weight | 2 | 1999 | 2255 | 0.070 |
Why?
|
| Efferent Pathways | 2 | 2003 | 167 | 0.070 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2010 | 670 | 0.070 |
Why?
|
| Catalysis | 1 | 2007 | 760 | 0.070 |
Why?
|
| Recombination, Genetic | 1 | 2011 | 1586 | 0.070 |
Why?
|
| Chromosomal Instability | 1 | 2007 | 184 | 0.070 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2007 | 713 | 0.070 |
Why?
|
| Nifedipine | 3 | 1996 | 226 | 0.070 |
Why?
|
| Oxidation-Reduction | 2 | 2003 | 2187 | 0.070 |
Why?
|
| Mice, SCID | 2 | 2008 | 2715 | 0.070 |
Why?
|
| Age Distribution | 1 | 2012 | 2900 | 0.070 |
Why?
|
| Cholecystokinin | 1 | 1986 | 114 | 0.070 |
Why?
|
| Aneuploidy | 1 | 2009 | 530 | 0.070 |
Why?
|
| Esophageal Stenosis | 4 | 2001 | 194 | 0.070 |
Why?
|
| Emergencies | 1 | 2012 | 1164 | 0.060 |
Why?
|
| Microscopy, Confocal | 1 | 2011 | 1969 | 0.060 |
Why?
|
| Cell Count | 2 | 2009 | 1831 | 0.060 |
Why?
|
| Fixatives | 1 | 2004 | 94 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2019 | 6249 | 0.060 |
Why?
|
| Inflammation | 2 | 2024 | 10578 | 0.060 |
Why?
|
| Gastritis | 3 | 1998 | 191 | 0.060 |
Why?
|
| Anthraquinones | 1 | 2004 | 35 | 0.060 |
Why?
|
| Serine | 1 | 2008 | 828 | 0.060 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2010 | 1114 | 0.060 |
Why?
|
| Arginine | 3 | 1993 | 944 | 0.060 |
Why?
|
| Dithionitrobenzoic Acid | 1 | 2003 | 21 | 0.060 |
Why?
|
| Sulfhydryl Reagents | 1 | 2003 | 32 | 0.060 |
Why?
|
| Dithiothreitol | 1 | 2003 | 101 | 0.060 |
Why?
|
| Lasers | 1 | 2008 | 952 | 0.060 |
Why?
|
| Ammonium Chloride | 1 | 2003 | 74 | 0.060 |
Why?
|
| Hypnotics and Sedatives | 1 | 2012 | 1158 | 0.060 |
Why?
|
| Tosyl Compounds | 1 | 2003 | 110 | 0.060 |
Why?
|
| Paraffin Embedding | 1 | 2004 | 299 | 0.060 |
Why?
|
| Ganglia, Parasympathetic | 1 | 2003 | 18 | 0.060 |
Why?
|
| Catheterization | 2 | 1988 | 1468 | 0.060 |
Why?
|
| Photosensitizing Agents | 1 | 2007 | 602 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 1213 | 0.060 |
Why?
|
| Receptors, Drug | 3 | 1978 | 161 | 0.060 |
Why?
|
| Oxidants | 1 | 2003 | 164 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2009 | 3701 | 0.060 |
Why?
|
| Formaldehyde | 1 | 2004 | 353 | 0.060 |
Why?
|
| Histamine | 6 | 1978 | 507 | 0.050 |
Why?
|
| Serotonin | 2 | 1978 | 1024 | 0.050 |
Why?
|
| Ganglia | 2 | 1996 | 89 | 0.050 |
Why?
|
| Biophysical Phenomena | 1 | 2003 | 327 | 0.050 |
Why?
|
| Sulfonamides | 1 | 2012 | 1932 | 0.050 |
Why?
|
| Hookworm Infections | 4 | 1976 | 13 | 0.050 |
Why?
|
| Receptors, Opioid | 1 | 1983 | 155 | 0.050 |
Why?
|
| Myristic Acid | 1 | 2002 | 47 | 0.050 |
Why?
|
| Disease Progression | 3 | 2007 | 13256 | 0.050 |
Why?
|
| Biophysics | 1 | 2003 | 383 | 0.050 |
Why?
|
| Radiography | 3 | 2012 | 7010 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2000 | 534 | 0.050 |
Why?
|
| Hemagglutinins | 1 | 2002 | 117 | 0.050 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2002 | 100 | 0.050 |
Why?
|
| Photochemotherapy | 1 | 2007 | 804 | 0.050 |
Why?
|
| Porphyrins | 1 | 2003 | 348 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2009 | 1989 | 0.050 |
Why?
|
| Actins | 2 | 1999 | 2120 | 0.050 |
Why?
|
| Bethanechol Compounds | 4 | 1986 | 10 | 0.050 |
Why?
|
| Fourth Ventricle | 1 | 2000 | 30 | 0.050 |
Why?
|
| Solitary Nucleus | 1 | 2001 | 63 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2007 | 10472 | 0.050 |
Why?
|
| Anastomosis, Surgical | 1 | 2004 | 985 | 0.050 |
Why?
|
| Narcotics | 1 | 1983 | 343 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2000 | 689 | 0.050 |
Why?
|
| Laryngeal Cartilages | 1 | 2000 | 22 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 14720 | 0.050 |
Why?
|
| Ferricyanides | 1 | 1980 | 32 | 0.050 |
Why?
|
| Indomethacin | 2 | 1993 | 331 | 0.050 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2002 | 494 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2007 | 2699 | 0.050 |
Why?
|
| Cisapride | 1 | 1999 | 22 | 0.050 |
Why?
|
| Binding, Competitive | 2 | 1999 | 1159 | 0.050 |
Why?
|
| Hydrogen Peroxide | 1 | 2003 | 730 | 0.050 |
Why?
|
| Neural Conduction | 2 | 1992 | 468 | 0.050 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 1 | 1999 | 70 | 0.040 |
Why?
|
| Gastrointestinal Hormones | 2 | 1977 | 97 | 0.040 |
Why?
|
| Cell Line, Tumor | 4 | 2011 | 16665 | 0.040 |
Why?
|
| Isoproterenol | 5 | 1978 | 399 | 0.040 |
Why?
|
| Verapamil | 1 | 1980 | 244 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2006 | 3504 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 11 | 1988 | 10943 | 0.040 |
Why?
|
| Diaphragm | 1 | 2000 | 347 | 0.040 |
Why?
|
| Protein Kinase C | 2 | 2002 | 1227 | 0.040 |
Why?
|
| Diagnosis, Differential | 2 | 2012 | 12958 | 0.040 |
Why?
|
| Time Factors | 8 | 2005 | 40054 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 1997 | 2455 | 0.040 |
Why?
|
| Charybdotoxin | 1 | 1998 | 24 | 0.040 |
Why?
|
| Ethylamines | 1 | 1998 | 17 | 0.040 |
Why?
|
| Oxadiazoles | 1 | 1998 | 93 | 0.040 |
Why?
|
| Phenotype | 2 | 2008 | 16331 | 0.040 |
Why?
|
| Prognosis | 1 | 2019 | 29010 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2009 | 2915 | 0.040 |
Why?
|
| Aminoquinolines | 1 | 1998 | 109 | 0.040 |
Why?
|
| Tropomyosin | 1 | 1998 | 102 | 0.040 |
Why?
|
| Gastrointestinal Agents | 2 | 2001 | 494 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2009 | 5975 | 0.040 |
Why?
|
| Receptors, Cell Surface | 2 | 1986 | 2867 | 0.040 |
Why?
|
| Genome, Human | 1 | 2011 | 4420 | 0.040 |
Why?
|
| Epithelial Cells | 2 | 2008 | 3678 | 0.040 |
Why?
|
| Benzylidene Compounds | 1 | 1997 | 27 | 0.040 |
Why?
|
| Genistein | 1 | 1997 | 84 | 0.040 |
Why?
|
| Vagotomy | 3 | 1988 | 83 | 0.040 |
Why?
|
| Injections, Intravenous | 7 | 1978 | 1420 | 0.040 |
Why?
|
| Potassium Chloride | 1 | 1997 | 238 | 0.040 |
Why?
|
| Genotype | 1 | 2011 | 12946 | 0.040 |
Why?
|
| Ionomycin | 1 | 1996 | 109 | 0.040 |
Why?
|
| Multiple Myeloma | 2 | 2006 | 5169 | 0.040 |
Why?
|
| Chickens | 1 | 1999 | 865 | 0.040 |
Why?
|
| Propranolol | 5 | 1977 | 502 | 0.040 |
Why?
|
| Quinoxalines | 1 | 1998 | 288 | 0.040 |
Why?
|
| Hexamethonium Compounds | 5 | 1978 | 23 | 0.040 |
Why?
|
| Hernia, Diaphragmatic | 1 | 1977 | 250 | 0.040 |
Why?
|
| Isoflavones | 1 | 1997 | 139 | 0.040 |
Why?
|
| Muscles | 4 | 1992 | 1617 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2011 | 4933 | 0.030 |
Why?
|
| Mucins | 1 | 1999 | 564 | 0.030 |
Why?
|
| Skin | 1 | 1990 | 4353 | 0.030 |
Why?
|
| Retrospective Studies | 5 | 2012 | 77098 | 0.030 |
Why?
|
| Cricoid Cartilage | 1 | 1996 | 72 | 0.030 |
Why?
|
| Prostaglandins E | 1 | 1975 | 172 | 0.030 |
Why?
|
| Tetraethylammonium Compounds | 1 | 1995 | 32 | 0.030 |
Why?
|
| Piperidines | 1 | 2004 | 1602 | 0.030 |
Why?
|
| Tetraethylammonium | 1 | 1995 | 58 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2012 | 5522 | 0.030 |
Why?
|
| Muscarine | 1 | 1995 | 8 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1991 | 2505 | 0.030 |
Why?
|
| Middle Aged | 30 | 2007 | 213127 | 0.030 |
Why?
|
| Egtazic Acid | 1 | 1995 | 173 | 0.030 |
Why?
|
| NADPH Dehydrogenase | 1 | 1994 | 45 | 0.030 |
Why?
|
| Helicobacter pylori | 1 | 1998 | 381 | 0.030 |
Why?
|
| Phentolamine | 4 | 1976 | 104 | 0.030 |
Why?
|
| Helicobacter Infections | 1 | 1998 | 385 | 0.030 |
Why?
|
| 4-Aminopyridine | 1 | 1995 | 81 | 0.030 |
Why?
|
| Models, Animal | 1 | 2001 | 2170 | 0.030 |
Why?
|
| Gene Expression Profiling | 3 | 2006 | 9410 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2021 | 2638 | 0.030 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 1994 | 135 | 0.030 |
Why?
|
| Europe | 1 | 2001 | 3339 | 0.030 |
Why?
|
| Peptic Ulcer | 2 | 1966 | 223 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2005 | 2616 | 0.030 |
Why?
|
| Cadmium | 1 | 1995 | 212 | 0.030 |
Why?
|
| Aged | 19 | 2007 | 162944 | 0.030 |
Why?
|
| Cytoplasm | 1 | 1998 | 1539 | 0.030 |
Why?
|
| Organ Specificity | 1 | 1998 | 2003 | 0.030 |
Why?
|
| Adult | 31 | 2012 | 213712 | 0.030 |
Why?
|
| Cytodiagnosis | 1 | 1997 | 435 | 0.030 |
Why?
|
| Reference Values | 1 | 2000 | 4982 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 8300 | 0.030 |
Why?
|
| Theophylline | 1 | 1973 | 132 | 0.030 |
Why?
|
| Tachyphylaxis | 3 | 1978 | 51 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 1996 | 931 | 0.030 |
Why?
|
| Culture Techniques | 1 | 1993 | 554 | 0.030 |
Why?
|
| Parasympathetic Nervous System | 3 | 1978 | 141 | 0.030 |
Why?
|
| Reserpine | 3 | 1977 | 66 | 0.030 |
Why?
|
| 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid | 1 | 1991 | 34 | 0.030 |
Why?
|
| Nitriles | 1 | 1997 | 952 | 0.030 |
Why?
|
| 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 1 | 1991 | 60 | 0.030 |
Why?
|
| Parasympatholytics | 2 | 1971 | 91 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 6608 | 0.030 |
Why?
|
| Cats | 2 | 1986 | 998 | 0.030 |
Why?
|
| Fluoroscopy | 1 | 1996 | 924 | 0.030 |
Why?
|
| Ki-67 Antigen | 2 | 2007 | 644 | 0.030 |
Why?
|
| Ouabain | 1 | 1991 | 264 | 0.020 |
Why?
|
| Calcium Channels | 1 | 1995 | 621 | 0.020 |
Why?
|
| Hypercalcemia | 1 | 1974 | 405 | 0.020 |
Why?
|
| Evoked Potentials | 2 | 1989 | 1057 | 0.020 |
Why?
|
| Rats | 4 | 2004 | 24265 | 0.020 |
Why?
|
| Solutions | 1 | 1991 | 426 | 0.020 |
Why?
|
| Child, Preschool | 4 | 2012 | 40955 | 0.020 |
Why?
|
| Cell Line | 1 | 2005 | 15994 | 0.020 |
Why?
|
| Differential Threshold | 1 | 1990 | 80 | 0.020 |
Why?
|
| Ions | 1 | 1991 | 264 | 0.020 |
Why?
|
| Infant | 3 | 2012 | 35070 | 0.020 |
Why?
|
| Cell Division | 3 | 2004 | 4564 | 0.020 |
Why?
|
| Microelectrodes | 1 | 1991 | 303 | 0.020 |
Why?
|
| Receptors, Bradykinin | 1 | 1990 | 19 | 0.020 |
Why?
|
| Nicotine | 1 | 1975 | 677 | 0.020 |
Why?
|
| Pancreas | 1 | 1996 | 1684 | 0.020 |
Why?
|
| Permeability | 1 | 1991 | 738 | 0.020 |
Why?
|
| Adolescent | 14 | 2012 | 85649 | 0.020 |
Why?
|
| Mass Screening | 1 | 2005 | 5238 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2005 | 8425 | 0.020 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 1991 | 494 | 0.020 |
Why?
|
| Physical Stimulation | 1 | 1990 | 525 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2011 | 678 | 0.020 |
Why?
|
| Dopamine | 1 | 1976 | 1589 | 0.020 |
Why?
|
| Central Nervous System | 1 | 1996 | 1354 | 0.020 |
Why?
|
| Mandelic Acids | 1 | 1968 | 47 | 0.020 |
Why?
|
| Spider Venoms | 1 | 1988 | 44 | 0.020 |
Why?
|
| Reaction Time | 2 | 1984 | 2092 | 0.020 |
Why?
|
| Models, Neurological | 1 | 1996 | 1771 | 0.020 |
Why?
|
| Endoscopy | 2 | 1997 | 1774 | 0.020 |
Why?
|
| Risk Factors | 2 | 2005 | 72145 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2005 | 7276 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2012 | 62966 | 0.020 |
Why?
|
| Gastrointestinal Diseases | 1 | 1996 | 1167 | 0.020 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2007 | 859 | 0.020 |
Why?
|
| Histological Techniques | 1 | 1987 | 198 | 0.020 |
Why?
|
| Prostaglandin Antagonists | 2 | 1980 | 30 | 0.020 |
Why?
|
| Peripheral Nerves | 1 | 1991 | 474 | 0.020 |
Why?
|
| Hypotension | 1 | 1973 | 880 | 0.020 |
Why?
|
| Blood Pressure | 4 | 1988 | 8541 | 0.020 |
Why?
|
| Bethanechol | 1 | 1986 | 13 | 0.020 |
Why?
|
| Receptors, Laminin | 1 | 2006 | 26 | 0.020 |
Why?
|
| Injections, Intra-Arterial | 2 | 1978 | 193 | 0.020 |
Why?
|
| Cimetidine | 1 | 1986 | 78 | 0.020 |
Why?
|
| Receptors, Serotonin | 2 | 1978 | 210 | 0.020 |
Why?
|
| Proglumide | 1 | 1986 | 3 | 0.020 |
Why?
|
| Receptors, Cholecystokinin | 1 | 1986 | 18 | 0.020 |
Why?
|
| Sincalide | 1 | 1986 | 16 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 1999 | 5095 | 0.020 |
Why?
|
| Antacids | 1 | 1986 | 99 | 0.020 |
Why?
|
| Cold Temperature | 1 | 1989 | 774 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2021 | 13029 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2007 | 462 | 0.020 |
Why?
|
| Secretory Rate | 4 | 1976 | 82 | 0.020 |
Why?
|
| Child | 5 | 2012 | 77478 | 0.020 |
Why?
|
| Cholinergic Fibers | 1 | 1985 | 68 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2001 | 2552 | 0.020 |
Why?
|
| Rest | 1 | 1990 | 900 | 0.020 |
Why?
|
| Pentagastrin | 2 | 1976 | 17 | 0.020 |
Why?
|
| Alkaline Phosphatase | 3 | 1974 | 865 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2004 | 18006 | 0.020 |
Why?
|
| Rabbits | 3 | 1996 | 4886 | 0.020 |
Why?
|
| Antibodies | 4 | 2001 | 2459 | 0.020 |
Why?
|
| Tea | 1 | 2006 | 275 | 0.020 |
Why?
|
| Axons | 1 | 1992 | 1681 | 0.020 |
Why?
|
| Refractory Period, Electrophysiological | 1 | 1984 | 39 | 0.020 |
Why?
|
| Phytotherapy | 1 | 2006 | 298 | 0.010 |
Why?
|
| Weight Loss | 1 | 1995 | 2604 | 0.010 |
Why?
|
| Analgesics | 1 | 1991 | 1037 | 0.010 |
Why?
|
| Models, Biological | 2 | 1997 | 9581 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 1972 | 2211 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2004 | 24913 | 0.010 |
Why?
|
| Meperidine | 1 | 1983 | 38 | 0.010 |
Why?
|
| Sex Factors | 2 | 1994 | 10392 | 0.010 |
Why?
|
| Incidence | 1 | 2001 | 20928 | 0.010 |
Why?
|
| Deoxyribonuclease I | 1 | 2003 | 228 | 0.010 |
Why?
|
| Anemia | 3 | 1968 | 1499 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1998 | 19223 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1991 | 6365 | 0.010 |
Why?
|
| Fetal Proteins | 2 | 1972 | 94 | 0.010 |
Why?
|
| Drug Interactions | 2 | 1978 | 1458 | 0.010 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 1987 | 960 | 0.010 |
Why?
|
| Prevalence | 2 | 1996 | 15194 | 0.010 |
Why?
|
| Keratin-20 | 1 | 2001 | 31 | 0.010 |
Why?
|
| Sensory Receptor Cells | 2 | 1977 | 487 | 0.010 |
Why?
|
| Keratin-7 | 1 | 2001 | 57 | 0.010 |
Why?
|
| G-Quadruplexes | 1 | 2003 | 162 | 0.010 |
Why?
|
| Syndrome | 2 | 1977 | 3248 | 0.010 |
Why?
|
| Gastric Acidity Determination | 3 | 1976 | 62 | 0.010 |
Why?
|
| Naloxone | 1 | 1983 | 367 | 0.010 |
Why?
|
| Sialomucins | 1 | 1999 | 15 | 0.010 |
Why?
|
| Fundoplication | 1 | 2001 | 138 | 0.010 |
Why?
|
| Liver Neoplasms | 3 | 1972 | 4249 | 0.010 |
Why?
|
| Hepatitis B virus | 3 | 1972 | 513 | 0.010 |
Why?
|
| Intermediate Filament Proteins | 1 | 2001 | 269 | 0.010 |
Why?
|
| Prospective Studies | 4 | 1999 | 53187 | 0.010 |
Why?
|
| Keratins | 1 | 2001 | 515 | 0.010 |
Why?
|
| Aged, 80 and over | 5 | 2007 | 57683 | 0.010 |
Why?
|
| Cardia | 1 | 1998 | 57 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1999 | 718 | 0.010 |
Why?
|
| N,N-Dimethyltryptamine | 1 | 1978 | 4 | 0.010 |
Why?
|
| Fenclonine | 1 | 1978 | 16 | 0.010 |
Why?
|
| Betazole | 1 | 1978 | 1 | 0.010 |
Why?
|
| Antigens, Nuclear | 1 | 1999 | 192 | 0.010 |
Why?
|
| Tubocurarine | 1 | 1978 | 63 | 0.010 |
Why?
|
| Receptors, Histamine | 1 | 1978 | 22 | 0.010 |
Why?
|
| p-Methoxy-N-methylphenethylamine | 1 | 1978 | 41 | 0.010 |
Why?
|
| Receptors, Prostaglandin | 1 | 1978 | 57 | 0.010 |
Why?
|
| Sympatholytics | 1 | 1978 | 83 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1974 | 4029 | 0.010 |
Why?
|
| Respiration | 2 | 1978 | 1645 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2006 | 2382 | 0.010 |
Why?
|
| Diphenhydramine | 1 | 1978 | 63 | 0.010 |
Why?
|
| Receptors, Adrenergic | 1 | 1978 | 155 | 0.010 |
Why?
|
| Pyloric Antrum | 1 | 1977 | 68 | 0.010 |
Why?
|
| Histamine Antagonists | 1 | 1978 | 93 | 0.010 |
Why?
|
| 5-Methoxytryptamine | 1 | 1977 | 1 | 0.010 |
Why?
|
| Methysergide | 1 | 1977 | 28 | 0.010 |
Why?
|
| India | 4 | 1971 | 2187 | 0.010 |
Why?
|
| Receptors, Dopamine | 1 | 1978 | 294 | 0.010 |
Why?
|
| Receptors, Cholinergic | 1 | 1978 | 238 | 0.010 |
Why?
|
| Metiamide | 1 | 1976 | 6 | 0.010 |
Why?
|
| Serotonin Antagonists | 1 | 1977 | 146 | 0.010 |
Why?
|
| Heart Rate | 1 | 1987 | 4091 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 1976 | 191 | 0.010 |
Why?
|
| Anemia, Hypochromic | 1 | 1976 | 66 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2001 | 1866 | 0.010 |
Why?
|
| Pyrimidines | 1 | 1968 | 2933 | 0.010 |
Why?
|
| Autonomic Fibers, Postganglionic | 1 | 1975 | 5 | 0.010 |
Why?
|
| Hernia, Hiatal | 1 | 1976 | 79 | 0.010 |
Why?
|
| Ganglionic Stimulants | 1 | 1975 | 19 | 0.010 |
Why?
|
| Immune Sera | 1 | 1976 | 641 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 6313 | 0.010 |
Why?
|
| Phenylephrine | 1 | 1976 | 301 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 1999 | 1099 | 0.010 |
Why?
|
| Poliomyelitis | 1 | 1976 | 103 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1978 | 2645 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1997 | 1676 | 0.010 |
Why?
|
| Haloperidol | 1 | 1976 | 397 | 0.010 |
Why?
|
| Glycogen | 1 | 1994 | 260 | 0.010 |
Why?
|
| Risk | 1 | 1986 | 9679 | 0.010 |
Why?
|
| Muscular Dystrophies | 1 | 1976 | 393 | 0.010 |
Why?
|
| Myasthenia Gravis | 1 | 1976 | 201 | 0.010 |
Why?
|
| Coronary Disease | 1 | 1988 | 6078 | 0.010 |
Why?
|
| Neuromuscular Diseases | 1 | 1976 | 253 | 0.010 |
Why?
|
| Nicotinic Acids | 1 | 1973 | 31 | 0.010 |
Why?
|
| United States | 1 | 2001 | 69693 | 0.010 |
Why?
|
| Pentobarbital | 1 | 1973 | 155 | 0.010 |
Why?
|
| Myositis | 1 | 1976 | 251 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2007 | 39004 | 0.010 |
Why?
|
| Sulfur Isotopes | 1 | 1972 | 24 | 0.010 |
Why?
|
| Immunodiffusion | 1 | 1972 | 163 | 0.010 |
Why?
|
| Blood Protein Electrophoresis | 1 | 1972 | 73 | 0.010 |
Why?
|
| Electromyography | 1 | 1978 | 1391 | 0.010 |
Why?
|
| Phosphorus | 1 | 1974 | 338 | 0.010 |
Why?
|
| Colloids | 1 | 1972 | 136 | 0.010 |
Why?
|
| Technetium | 1 | 1972 | 334 | 0.010 |
Why?
|
| Adenoma, Bile Duct | 1 | 1971 | 30 | 0.010 |
Why?
|
| Alpha-Globulins | 1 | 1971 | 29 | 0.010 |
Why?
|
| Zollinger-Ellison Syndrome | 1 | 1971 | 15 | 0.010 |
Why?
|
| Rose Bengal | 1 | 1972 | 115 | 0.010 |
Why?
|
| Antineoplastic Agents | 2 | 2006 | 13655 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2008 | 8925 | 0.010 |
Why?
|
| Methods | 1 | 1971 | 1128 | 0.010 |
Why?
|
| Gene Expression | 1 | 2004 | 7790 | 0.010 |
Why?
|
| Stem Cells | 1 | 2004 | 3563 | 0.010 |
Why?
|
| Pancreatic Ducts | 1 | 1972 | 328 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1994 | 1902 | 0.010 |
Why?
|
| Cause of Death | 1 | 2001 | 3571 | 0.010 |
Why?
|
| Ascites | 1 | 1972 | 344 | 0.010 |
Why?
|
| Methionine | 1 | 1972 | 590 | 0.010 |
Why?
|
| Selenium | 1 | 1972 | 402 | 0.010 |
Why?
|
| Connective Tissue | 1 | 1971 | 420 | 0.010 |
Why?
|
| Cerebrovascular Disorders | 1 | 1976 | 1499 | 0.010 |
Why?
|
| Movement | 1 | 1976 | 1470 | 0.010 |
Why?
|
| Binding Sites | 1 | 1978 | 6115 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1973 | 1470 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1972 | 1030 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1973 | 1791 | 0.010 |
Why?
|
| Hepatitis B Antigens | 3 | 1972 | 40 | 0.000 |
Why?
|
| Radionuclide Imaging | 1 | 1972 | 2027 | 0.000 |
Why?
|
| Survival Analysis | 1 | 2001 | 10248 | 0.000 |
Why?
|
| Hemoglobinometry | 1 | 1967 | 35 | 0.000 |
Why?
|
| Autopsy | 1 | 1971 | 1006 | 0.000 |
Why?
|
| Ethnology | 1 | 1966 | 5 | 0.000 |
Why?
|
| Tetanus Antitoxin | 1 | 1966 | 8 | 0.000 |
Why?
|
| Antibody Formation | 1 | 1972 | 1402 | 0.000 |
Why?
|
| Tetanus | 1 | 1966 | 53 | 0.000 |
Why?
|
| Anesthesia | 1 | 1978 | 1548 | 0.000 |
Why?
|
| Imidazoles | 1 | 1973 | 1205 | 0.000 |
Why?
|
| Proportional Hazards Models | 1 | 2001 | 12344 | 0.000 |
Why?
|
| Mutation | 1 | 2011 | 29717 | 0.000 |
Why?
|
| Hepatitis B | 1 | 1971 | 695 | 0.000 |
Why?
|
| Stress, Mechanical | 1 | 1971 | 1684 | 0.000 |
Why?
|
| Antigens | 1 | 1971 | 1462 | 0.000 |
Why?
|
| Pancreatitis | 1 | 1972 | 1090 | 0.000 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2001 | 9941 | 0.000 |
Why?
|
| Nuclear Proteins | 1 | 1999 | 5851 | 0.000 |
Why?
|
| Down Syndrome | 1 | 1972 | 880 | 0.000 |
Why?
|
| Infant, Newborn | 2 | 1976 | 25575 | 0.000 |
Why?
|
| Placebos | 1 | 1968 | 1677 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1974 | 4839 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 2001 | 15530 | 0.000 |
Why?
|
| Liver Diseases | 1 | 1971 | 1252 | 0.000 |
Why?
|
| Complement Fixation Tests | 2 | 1972 | 78 | 0.000 |
Why?
|
| Immunoelectrophoresis | 2 | 1972 | 110 | 0.000 |
Why?
|
| Parkinson Disease | 1 | 1976 | 2774 | 0.000 |
Why?
|
| Bone Neoplasms | 1 | 1974 | 2522 | 0.000 |
Why?
|
| Hemorrhage | 1 | 1973 | 3461 | 0.000 |
Why?
|
| Multiple Sclerosis | 1 | 1976 | 3076 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 1999 | 21719 | 0.000 |
Why?
|
| Proteins | 1 | 1996 | 6096 | 0.000 |
Why?
|
| Brain | 1 | 1988 | 26343 | 0.000 |
Why?
|
| Age Factors | 2 | 1972 | 18355 | 0.000 |
Why?
|
| Schizophrenia | 1 | 1976 | 6874 | 0.000 |
Why?
|
| Clinical Trials as Topic | 2 | 1968 | 7901 | 0.000 |
Why?
|
| Stimulation, Chemical | 1 | 1974 | 326 | 0.000 |
Why?
|
| Hemagglutination Tests | 1 | 1972 | 75 | 0.000 |
Why?
|
| Amylases | 1 | 1972 | 172 | 0.000 |
Why?
|
| Ascitic Fluid | 1 | 1972 | 192 | 0.000 |
Why?
|
| Immune Adherence Reaction | 1 | 1971 | 32 | 0.000 |
Why?
|
| Propantheline | 1 | 1971 | 6 | 0.000 |
Why?
|
| Electrophoresis | 1 | 1971 | 240 | 0.000 |
Why?
|
| Glycopyrrolate | 1 | 1971 | 33 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1972 | 918 | 0.000 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1971 | 363 | 0.000 |
Why?
|
| Liver Cirrhosis | 2 | 1971 | 1864 | 0.000 |
Why?
|
| Immunologic Techniques | 1 | 1971 | 218 | 0.000 |
Why?
|
| Hepatitis A | 1 | 1971 | 133 | 0.000 |
Why?
|
| Rupture | 1 | 1972 | 430 | 0.000 |
Why?
|
| Texas | 1 | 1972 | 392 | 0.000 |
Why?
|
| Nutrition Disorders | 1 | 1971 | 211 | 0.000 |
Why?
|
| Lipase | 1 | 1972 | 315 | 0.000 |
Why?
|
| Hospitals, Psychiatric | 1 | 1972 | 332 | 0.000 |
Why?
|
| Hepatitis | 1 | 1971 | 227 | 0.000 |
Why?
|
| ABO Blood-Group System | 1 | 1971 | 367 | 0.000 |
Why?
|
| Cholestasis | 1 | 1971 | 378 | 0.000 |
Why?
|
| Carrier State | 1 | 1972 | 518 | 0.000 |
Why?
|
| Long-Term Care | 1 | 1972 | 607 | 0.000 |
Why?
|
| Immunoglobulins | 1 | 1971 | 880 | 0.000 |
Why?
|
| Immunoassay | 1 | 1971 | 752 | 0.000 |
Why?
|
| Laryngismus | 1 | 1966 | 28 | 0.000 |
Why?
|
| Kinetics | 1 | 1974 | 6474 | 0.000 |
Why?
|
| Body Weight | 1 | 1974 | 4664 | 0.000 |
Why?
|
| Renal Dialysis | 1 | 1971 | 1780 | 0.000 |
Why?
|
| Hemoglobins | 1 | 1968 | 1532 | 0.000 |
Why?
|
| Hospitalization | 2 | 1972 | 10232 | 0.000 |
Why?
|
| Fever | 1 | 1966 | 1612 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1972 | 9144 | 0.000 |
Why?
|
| Liver | 1 | 1971 | 7470 | 0.000 |
Why?
|